PALIPERIDONE ER TREATMENT AND THE IMPROVEMENT OF SOCIAL AND COGNITIVE FUNCTION IN PATIENTS WITH SCHIZOPHRENICS - A 24-WEEK, SINGLE ARM, OPEN-LABEL STUDY

被引：2
|
作者：
Shi, Chuan [1 ]
Yu, Xin [1 ]
Kang, Lan [1 ]
Yao, Shuqiao [2 ]
Tang, Xirong [2 ]
Xu, Yifeng [3 ]
Peng, Daihui [3 ]
Shi, Jianguo [4 ]
Lin, Huali [4 ]
Xu, Xiufeng [5 ]
Liu, Fang [5 ]
Zhang, Congpei [6 ]
Wang, Xijin [6 ]
机构：
[1] Peking Univ, Inst Mental Hlth, Beijing, Peoples R China
[2] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
[3] Shanghai Jiao Tong Univ, Inst Mental Hlth, Shanghai, Peoples R China
[4] Xian Mental Hlth Ctr, Xian, Shaanxi, Peoples R China
[5] Kunming Med Sch, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
[6] First Haerbin Psychiat Hosp, Harbin, Heilongjiang, Peoples R China
来源：
SCHIZOPHRENIA RESEARCH | 2014年 / 153卷
关键词：
D O I：
10.1016/S0920-9964(14)70362-7
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
S83
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [21] A Multicenter, Open-Label, 24-Week Follow-Up Study for Efficacy on Cognitive Function of Donepezil in Binswanger-Type Subcortical Vascular Dementia
    Kwon, Jay Cheol
    Kim, Eung Gyu
    Kim, Jae Woo
    Kwon, Oh Dae
    Yoo, Bong Goo
    Yi, Hyon Ah
    Choi, Nack Cheon
    Ahn, Seon Young
    Lee, Byung Hwa
    Kang, Myong Jin
    Choi, Dae Seob
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2009, 24 (04): : 293 - 301
  • [22] A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression
    Corya, S
    Williamson, D
    Case, M
    Lin, D
    Tohen, M
    EUROPEAN PSYCHIATRY, 2005, 20 : S139 - S139
  • [23] A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression
    Corya, SA
    Perlis, RH
    Keck, PE
    Lin, DY
    Case, MG
    Williamson, DJ
    Tohen, MF
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (05) : 798 - 806
  • [24] Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study
    Elena P Calandre
    Piedad Morillas-Arques
    Rocío Molina-Barea
    Carmen M Rodriguez-Lopez
    Fernando Rico-Villademoros
    BMC Musculoskeletal Disorders, 12
  • [25] The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia
    Cheon, Younghoon
    Park, Jaewoo
    Joe, Keun-Ho
    Kim, Dai-Jin
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 (07): : 971 - 983
  • [26] A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia
    Gopal, S.
    Vijapurkar, U.
    Lim, P.
    Morozova, M.
    Eerdekens, M.
    Hough, D.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (05) : 685 - 697
  • [27] Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis
    Abe, Koji
    Aoki, Masashi
    Tsuji, Shoji
    Itoyama, Yasuto
    Sobue, Gen
    Togo, Masanori
    Hamada, Chikuma
    Sasaki, Hidenao
    Yabe, Lchiro
    Doi, Shizuki
    Warita, Hitoshi
    Lmai, Takashi
    Ito, Hiroaki
    Fukuchi, Mitsumasa
    Osumi, Etsuko
    Wada, Manabu
    Nakanol, Lmaharu
    Morita, Mitsuya
    Ogata, Katsuhisa
    Maruki, Yuichi
    Ito, Kimiko
    Kano, Osamu
    Yamazaki, IViineo
    Takahashi, Yuji
    Ishiura, Hiroyuki
    Ogino, Micko
    Koike, Ryoko
    Ishida, Chiho
    Uchiyama, Tsuyoshi
    Mizoguchi, Koichi
    Obi, Tomokazu
    Watanabe, Hirohisa
    Atsuta, Naoki
    Aiba, Ikuko
    Taniguchi, Akira
    Sawada, Hideyuki
    Hazama, Takanori
    Fujimura, Harutoshi
    Kusaka, Hirofumi
    Kunieda, Takenobu
    Kikuchi, Hiroshi
    Matsuo, Hidenori
    Ueyama, Hidetsug-U
    Uekawa, Kazutoshi
    Tanaka, Masahiko
    Akimoto, Makoto
    Nakamura, Kazue
    Ueda, Masaki
    Kotani, Kuniko
    Matsui, Hiroshi
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2017, 18 : 55 - 63
  • [28] A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone
    Newcomer, John W.
    Ratner, Robert E.
    Eriksson, Jan W.
    Emsley, Robin
    Meulien, Didier
    Miller, Frank
    Leonova-Edlund, Julia
    Leong, Ronald W.
    Brecher, Martin
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (04) : 487 - 499
  • [29] Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial
    Kim, Sung-Wan
    Chung, Young-Chul
    Lee, Yo-Han
    Lee, Jeong-Hoon
    Kim, Seon-Young
    Bae, Kyung-Yeol
    Kim, Jae-Min
    Shin, Il-Seon
    Yoon, Jin-Sang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (05) : 267 - 274
  • [30] Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: A randomized, open-label, controlled trial
    Kim, S. -W.
    Chung, Y. -C.
    Lee, Y. -H.
    Lee, J. -H.
    Kim, S. -Y.
    Bae, K-Y.
    Jang, J. -E.
    Kim, J. -M.
    Shin, I. -S.
    Yoon, J. -S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 53 - 53
12345